BCL2L1 and glioblastoma: Since PDCD4 is a known tumor suppressor, and is lost in a variety of tumors including GBM, we were interested in determining if this loss also corresponds with an increase in Bcl-xL, which would contribute to the highly chemoresistant nature of GBM tumors.